0
0
8/4/23 at 10:48pm
Organization
FDA.gov
Author
Office of the Commissioner
27 words
0
Comments
The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression
Create an account
or login to join the discussion